# Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients

> **NCT01455675** · PHASE3 · COMPLETED · sponsor: **Mukoviszidose Institut gGmbH** · enrollment: 164 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** IgY
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01455675
- **Lead sponsor:** Mukoviszidose Institut gGmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2017-06-27
- **Final completion:** 2017-06-27
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2017-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455675, "Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01455675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*